Guiding drug discovery through 2003.
- Published in:
- 2003
- Publication type:
- Editorial
Works matching IS 14741776 AND DT 2003 AND VI 2 AND IP 1
Results: 22
1
2
Therapeutic antibodies for human diseases at the dawn of the twenty-first century.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 52, doi. 10.1038/nrd984
- By:
- Publication type:
- Article
3
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 9, doi. 10.1038/nrd1000
- Publication type:
- Article
4
Adrenoceptor pharmacology: Variety is the spice of life.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 10, doi. 10.1038/nrd1002
- By:
- Publication type:
- Article
5
What makes a good forecaster?
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 83, doi. 10.1038/nrd1005
- By:
- Publication type:
- Article
6
The common technical document: the changing face of the New Drug Application.
- Published in:
- 2003
- By:
- Publication type:
- review
7
From the analyst's couch: Antithrombotic drug market.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 11, doi. 10.1038/nrd966
- By:
- Publication type:
- Article
8
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 10
- By:
- Publication type:
- Article
9
Scientific and therapeutic advances in antiplatelet therapy.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 15, doi. 10.1038/nrd985
- By:
- Publication type:
- Article
10
A Guide to Drug Discovery: Target selection in drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 63, doi. 10.1038/nrd986
- By:
- Publication type:
- Article
11
The emerging field of nanotube biotechnology.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 29, doi. 10.1038/nrd988
- By:
- Publication type:
- Article
12
Biotechnology: Putting a finger on gene expression.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 6, doi. 10.1038/nrd994
- By:
- Publication type:
- Article
13
Obesity: It goes straight to my hips.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 8, doi. 10.1038/nrd998
- By:
- Publication type:
- Article
14
Knockouts model the 100 best-selling drugs--will they model the next 100?
- Published in:
- 2003
- By:
- Publication type:
- review
15
Outlook: The further evolution of biotech.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 75, doi. 10.1038/nrd989
- By:
- Publication type:
- Article
16
Timeline: The Common Technical Document: the changing face of the New Drug Application.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 71, doi. 10.1038/nrd990
- By:
- Publication type:
- Article
17
Obesity: A high dose of JuNK for fat mice.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 5, doi. 10.1038/nrd993
- By:
- Publication type:
- Article
18
Fresh from the pipeline: Drotrecogin alpha (activated).
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 13, doi. 10.1038/nrd991
- By:
- Publication type:
- Article
19
Muscular degeneration: Body building best without myostatin.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 6, doi. 10.1038/nrd995
- By:
- Publication type:
- Article
20
Nsaids: Better design through chemistry.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 8, doi. 10.1038/nrd997
- By:
- Publication type:
- Article
21
Amyloid diseases: Assembly instructions.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 7, doi. 10.1038/nrd996
- By:
- Publication type:
- Article
22
Bone diseases: Leptin bares our bones, sympathetically.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 1, p. 9, doi. 10.1038/nrd999
- By:
- Publication type:
- Article